Lukas Alfons Huber#
Membership Number: | 6058 |
Membership type: | ORDINARY |
Section: | CELL & DEVELOPMENTAL BIOLOGY |
Elected: | 2022 |
Main Country of Residence: | AUSTRIA |
Homepage(s): | https://cellbiology.i-med.ac.at/ |
ORCID: | 0000-0003-1116-2120 |
Present and Previous Positions
- Since 2022 President of the Austrian Platform for Personalized Medicine (ÖPPM)
- Since 2017 President, Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT)
- 2013 - 2015 Austrian delegate in the International Agency for Research on Cancer-IARC Scientific Council (WHO)
- Founder and Co-Director of the Austrian Drug Screening Institute under the patronage of the Austrian Academy of Sciences (ÖAW)
- 2012 Appointment as Professor and Director Systems Pharmacology, University College Dublin, Ireland - declined
- 2010 - 2014 Austrian representative and Steering Committee member to the ESF Research Networking Program on “Frontiers in Functional Genomics”
- 2009 - 2020 Founder and CSO, Center for Personalized Medicine, ONCOTYROL, Innsbruck
- 2002 Call as Full Professor to the Medical University of Innsbruck, since then Director of the Institute of Cell Biology
- 1996 - 2002 Group Leader, Institute of Molecular Pathology, IMP, Vienna, Austria
- 1993 - 1995 Maître Assistant, Département de Biochimie, Université de Genève, Sciences II, Genève, Switzerland, Prof. Dr. Jean Gruenberg
- 1990 - 1993 Postdoc at the European Molecular Biology Laboratory (EMBL), Cell Biology Program, Heidelberg, Prof. Dr. Kai Simons
Fields of Scholarship
- Cancer
- Lysosomes
- Metabolism
- Rare diseases
- Stem cells ad human organoids
- Vesicular transport
- Cell differetiation
- Inflammation
- mTOR signaling
Honours and Awards
- 1990 Hoechst Preis
- 1995 Johnson and Johnson Focused Giving Grant
- 1995 Forschungspreis Deutsche Gesellschaft für Zellbiologie
- 1996 Dr. Johannes Tuba Preis für Alternsforschung
- 2007 CAST Technology Award
- 2020 Silver Lion for Engagement in Rare Disease Research
- 2015 - 2022 Teacher of the year in Human Medicine as well as in Molecular Medicine, Medical University of Innsbruck